Optanep Dosage/Direction for Use

Adults, including the elderly: For the prevention and treatment of pain and inflammation, the dose is 1 drop on the conjunctival sac of the affected eye(s) once a day beginning 1 day prior to cataract surgery, continued on the day of surgery, and for the first 2 weeks of the postoperative period. Treatment can be extended to the first 3 weeks of the postoperative period, as directed by the clinician. An additional drop should be administered 30 to 120 minutes prior to surgery.
For the reduction in the risk of postoperative macular edema associated with cataract surgery in diabetic patients, the dose is 1 drop of Nepafenac in the conjunctival sac of the affected eye(s) once daily beginning 1 day prior to cataract surgery, continued on the day of surgery and up to 60 days of the postoperative period as directed by the clinician.
An additional drop should be administered 30 to 120 minutes prior to surgery.
Once-daily dosing with Nepafenac 3 mg/mL eye drops, suspension provides the same total daily dose of Nepafenac as three-times-daily dosing with Nepafenac 1 mg/mL eye drops, suspension.
Special populations: Patients with renal or hepatic impairment: Nepafenac has not been studied in patients with hepatic disease or renal impairment. Nepafenac is eliminated primarily through biotransformation and the systemic exposure is very low following topical ocular administration. No dose adjustment is warranted in these patients.
Pediatric population: The safety and efficacy of Nepafenac in children and adolescents have not been established. No data are available. Its use is not recommended in these patients until further data become available.
Geriatric population: No overall differences in safety and effectiveness have been observed between elderly and younger patients.
May be taken as prescribed by the physician.
Method of administration: For ocular use.
Instruct the patients to shake the bottle well before use.
If more than one topical ophthalmic medicinal product is being used, the medicinal product must be administered at least 5 minutes apart. Eye ointments should be administered last.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. The bottle should be kept tightly closed when not in use.